Answers are grounded in this paper and cite their sources.
Review uncovers cell-autonomous, local, and systemic factors driving nutrient limitation in tumors, highlighting therapeutic metabolic vulnerabilities.
Proliferation requires that cells accumulate sufficient biomass to grow and divide. Cancer cells within tumors must acquire a variety of nutrients, and tumor growth slows or stops if necessary metabolites are not obtained in sufficient quantities. Importantly, the metabolic demands of cancer cells can be different from those of untransformed cells, and nutrient accessibility in tumors is different than in many normal tissues. Thus, cancer cell survival and proliferation may be limited by different metabolic factors than those that are necessary to maintain noncancerous cells. Understanding the variables that dictate which nutrients are critical to sustain tumor growth may identify vulnerabilities that could be used to treat cancer. This review examines the various cell-autonomous, local, and systemic factors that determine which nutrients are limiting for tumor growth.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: